EU indices up | TA focus on Dechra Pharmaceuticals


European stocks report | Associated British Foods | Dechra Pharmaceuticals | Volkswagen | Ageas...

Stocks (2)

Friday, European stocks were broadly lower. The Stoxx Europe 600 Index slid 1.3%, Germany's DAX 30 sank 1.7%, France's CAC 40 and U.K.'s FTSE 100 were down 0.9%.

70% of STOXX 600 constituents traded lower or unchanged Friday.
29% of the shares trade above their 20D MA vs 41% Thursday (below the 20D moving average).
50% of the shares trade above their 200D MA vs 52% Thursday (below the 20D moving average).

The Euro Stoxx 50 Volatility index added 2.7pts to 31.71, a new 52w high.

3mths relative high: Chemicals, Autos
3mths relative low: none

Europe Best 3 sectors
banks, basic resources, automobiles & parts

Europe worst 3 sectors
real estate, technology, utilities

The 10yr Bund yield fell 2bps to -0.49% (below its 20D MA). The 2yr-10yr yield spread fell 1bp to -23bps (below its 20D MA).

GE 07:00: Jul Industrial Production MoM, exp.: 8.9%
UK 08:30: Aug Halifax House Price Idx YoY, exp.: 3.8%
UK 08:30: Aug Halifax House Price Idx MoM, exp.: 1.6%
FR 14:00: 12-Mth BTF auction, exp.: -0.57%
FR 14:00: 6-Mth BTF auction, exp.: -0.58%
FR 14:00: 3-Mth BTF auction, exp.: -0.57%


In Asian trading hours, EUR/USD was little changed at 1.1835 while GBP/USD slipped to 1.3239. USD/JPY was steady at 106.28. 

Spot gold climbed to $1,938 an ounce.

Associated British Foods, a food processing and retailing company, posted a 4Q trading update: "Trading in the fourth quarter in both our food businesses and Primark exceeded our expectations. (...) All Primark stores reopened in May, June and July.  Since reopening we have traded strongly, attracting customers with our value-for-money offering and a welcoming and safe store environment.  Cumulative sales since reopening to the year-end are expected to be £2bn and our adjusted operating profit on an IFRS16 basis for the year, before exceptional items, is now expected to be at least at the top end of the previously advised £300-350m range."

Dechra Pharmaceuticals, a veterinary pharmaceuticals company, released full-year results: "Dechra delivered consolidated revenue of £515.1 million, representing an increase of 6.8% on the prior year. (...) Consolidated underlying operating profit of £128.3 million represents a 0.4% increase on the prior year. (...) Underlying diluted EPS grew by 1.7% to 92.19 pence. (...) The Board is proposing a final dividend of 24.00 pence per share (2019: 22.10 pence per share). Added to the interim dividend of 10.29 pence per share (2019: 9.50 pence per share), this brings the total dividend for the financial year ended 30 June 2020 to 34.29 pence per share (2019: 31.60 pence per share), representing 8.5% growth over the previous year."
From a weekly point of view, the share has broken above a symmetrical triangle following a consolidation area of 2 years. Furthermore, the 200WMA plays a support role. Above the 200WMA at 2400p look for 4000p and 4300p in extension.

Source: GAIN Capital, TradingView

Informa, a business intelligence group, was downgraded to "neutral" from "buy" at Goldman Sachs.

Volkswagen's, an automobile group, Traton is planning to make a fresh bid for U.S. heavy-truck company Navistar International, which it previously offered 2.9 billion dollars, reported Bloomberg citing people familiar with the matter.

Continental, automotive parts manufacturer, was upgraded to "neutral" from "underweight" at JPMorgan.

Hannover Re, a reinsurance group, was upgraded to "overweight" from "underweight" at JPMorgan.

Hapag-Lloyd, a shipping and container transportation company, was upgraded to "hold" from "reduce" at HSBC.

Suez's, an utility company, CEO Bertrand Camus in an interview with French newspaper Le Figaro that "the proposed deal by Veolia is an aberration and destructive for France". He added that the company's share price has been hurt by the coronavirus pandemic, the offer undervalues Suez's assets and is opportunistic.

Sanofi, a pharmaceutical group, will launch an IPO for its drug-ingredients division in the coming months, according to the company's chief in France Olivier Bogillot cited by France Inter radio.

Scor, a reinsurance company, was downgraded to "neutral" from "overweight" at JPMorgan.

Mapfre, a Spanish insurance company, was downgraded to "underweight" from "neutral" at JPMorgan.

Ageas, a Belgian insurance company, confirmed that it was approached recently by BE Group with "an indicative and highly conditional offer" on the company.  The company added that "the Ageas Board of Directors assessed the indicative proposal but considered it not realistic and has decided not to engage".

Swiss Life, an insurance group, was upgraded to "neutral" from "underweight" at JPMorgan.

More from Equities


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.